​

Cyclo Therapeutics (CYTH) Stock Forecast, Price Target & Predictions

OverviewRevenueFinancialsChart

CYTH Stock Forecast

Cyclo Therapeutics (CYTH) stock forecast, based on 5 Wall Street analysts, predicts a 12-month average price target of $0.95, with a high of $0.95 and a low of $0.95. This represents a 21.79% increase from the last price of $0.78.

High: $0.95 Avg: $0.95 Low: $0.95 Last Closed Price: $0.78

CYTH Stock Rating

Cyclo Therapeutics stock's rating consensus is Buy, based on 5 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 2 Buy (40.00%), 2 Hold (40.00%), 1 Sell (20.00%), and 0 Strong Sell (0.00%).

Buy
Total 5 0 1 2 2 Strong Sell Sell Hold Buy Strong Buy

CYTH Forecast vs Benchmarks

TypeNameUpside
StockCyclo Therapeutics21.79%
SectorHealthcare Stocks 25.20%
IndustrySpecialty & Generic Drug Manufacturers Stocks24.78%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$0.95
Last Closing Price$0.78$0.78$0.78
Upside/Downside--21.79%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Nov, 24-12--3
Oct, 24-32--5
Sep, 24-32--5
Aug, 24-3---3
Jul, 24-3---3
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 26, 2024Lucas WardAscendiant$0.95$0.7821.79%21.79%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Aug 26, 2024AscendiantBuyBuyhold
Aug 23, 2024H.C. WainwrightNeutraldowngrade
Sep 27, 2023Morgan StanleyUnderweightdowngrade
Sep 27, 2023Maxim GroupBuyupgrade
Mar 21, 2023BernsteinMarket Performinitialise

Financial Forecast

EPS Forecast

$-6 $-5 $-4 $-3 $-2 $-1 $0 $1 $2 $3 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-5.58$-2.25$-2.40$-1.23-----
Avg Forecast$-3.74$-1.82$-1.41$-1.12$-0.59$-0.50$-0.13$0.35$1.28
High Forecast$-5.61$-2.73$-2.14$-1.80$-0.95$-0.80$-0.21$-1.44$0.42
Low Forecast$-1.52$-0.74$-0.52$-0.36$-0.19$-0.16$-0.05$2.14$2.06
Surprise %49.20%23.63%70.21%9.82%-----

Revenue Forecast

$0 $40M $80M $120M $160M $200M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$903.38K$1.59M$1.38M$1.08M-----
Avg Forecast$1.01M$1.37M$2.38M$579.00K$1.13M$1.80M$28.54M$57.39M$117.36M
High Forecast$548.43K$746.48K$1.23M$577.92K$542.35K$1.01M$13.74M$27.62M$56.48M
Low Forecast$1.40M$1.90M$3.32M$580.07K$1.65M$2.58M$41.91M$84.26M$172.33M
Surprise %-10.38%15.58%-42.17%85.91%-----

Net Income Forecast

$-100M $-70M $-40M $-10M $20M $50M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-8.92M$-14.31M$-15.28M$-20.06M-----
Avg Forecast$-61.07M$-29.72M$-23.02M$-20.06M$-9.32M$-7.90M$-2.12M$-10.36M$20.90M
High Forecast$-91.67M$-44.61M$-34.92M$-29.42M$-15.50M$-13.14M$-3.49M$-23.53M$6.81M
Low Forecast$-24.88M$-12.11M$-8.54M$-5.95M$-3.14M$-2.66M$-756.09K$34.96M$33.63M
Surprise %-85.39%-51.87%-33.64%------

CYTH Forecast FAQ

Is Cyclo Therapeutics stock a buy?

Cyclo Therapeutics stock has a consensus rating of Buy, based on 5 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 2 Buy, 2 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Cyclo Therapeutics is a favorable investment for most analysts.

What is Cyclo Therapeutics's price target?

Cyclo Therapeutics's price target, set by 5 Wall Street analysts, averages $0.95 over the next 12 months. The price target range spans from $0.95 at the low end to $0.95 at the high end, suggesting a potential 21.79% change from the previous close price of $0.78.

How does Cyclo Therapeutics stock forecast compare to the average forecast of its sector, industry, and investment themes?

Cyclo Therapeutics stock forecast shows a 21.79% upside, underperforming the average forecast for the healthcare stocks sector (25.20%) and underperforming the specialty & generic drug manufacturers stocks industry (24.78%).

What is the breakdown of analyst ratings for Cyclo Therapeutics over the past three months?

  • November 2024: 0% Strong Buy, 33.33% Buy, 66.67% Hold, 0% Sell, 0% Strong Sell.
  • October 2024: 0% Strong Buy, 60.00% Buy, 40.00% Hold, 0% Sell, 0% Strong Sell.
  • September 2024: 0% Strong Buy, 60.00% Buy, 40.00% Hold, 0% Sell, 0% Strong Sell.

What is Cyclo Therapeutics’s EPS forecast?

Cyclo Therapeutics's average annual EPS forecast for its fiscal year ending in December is -0.59 for 2024, a -52.03% decrease from the reported $-1.23 in 2023. The prediction for 2025 is $-0.5, $-0.13 for 2026, $0.35 for 2027, and $1.28 for 2028.

What is Cyclo Therapeutics’s revenue forecast?

Cyclo Therapeutics's average annual revenue forecast for its fiscal year ending in December is $1.13M for 2024, a 4.70% increase from the reported $1.08M in 2023. The forecast for 2025 is $1.8M, $28.54M for 2026, $57.39M for 2027, and $117.36M for 2028.

What is Cyclo Therapeutics’s net income forecast?

For its fiscal year ending in December, Cyclo Therapeutics's average annual net income forecast is $-9.318M for 2024, reflecting a -53.54% decrease from the reported $-20.057M in 2023. The projection for 2025 is $-7.897M, $-2.123M for 2026, $-10.356M for 2027, and $20.9M for 2028.